Renovaro Provides Update to Definitive Agreement with Predictive Oncology
LOS ANGELES, April 04, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update regarding its Definitive Agreement with Predictive Oncology Predictive Oncology, Inc. (NASDAQ: POAI) to initiate the previously announced integration of AI/ML platform technologies, core laboratory capabilities and business development efforts in Europe and the United States.
Renovaro entered into a binding agreement merger agreement with Predictive Oncology, Inc. ('POI') dated January 1, 2025, and supplemented with the Extension Agreement dated February 28, 2025 (collectively, the 'Binding Agreements'). On April 3, 2025, Renovaro received an email from POI terminating the merger transaction. Renovaro's position is that POI must comply with the binding obligations thereunder and enter into an exclusive License Agreement as required in each of the Binding Agreements. Renovaro notes that POI is in breach of the Binding Agreements and has caused substantial damage to Renovaro for which it will seek redress. Failure to enter into an exclusive License Agreement on the terms set forth in the Binding Agreement on or before April 10, 2025, will cause Renovaro to seek all its legal remedies to recover all its damages and/or seek additional remedies to fully redress the breaches.
About Renovaro
Renovaro https://renovarogroup.com/ aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro Inc. includes RenovaroBio with its advanced cell-gene immunotherapy company and RenovaroCube that is leveraging AI for multi-omic diagnostics and drug development. For more information, visit www.renovarogroup.com.
Forward-Looking Statements
Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline, platform and fundraising. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as 'believes,' 'plans,' 'expects,' 'aims,' 'intends,' 'potential,' or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro's most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.
Investor RelationsChris TysonExecutive Vice PresidentMZ Group - MZ North America949-491-8235RENB@mzgroup.uswww.mzgroup.us
For media inquiries, please contact:karen@renovarocube.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
‘Keep an Eye on the Bigger Picture,' Says Morgan Stanley About Tesla Stock
Tesla (NASDAQ:TSLA) stock took a sharp hit last week after Elon Musk and Donald Trump – once close buddies – turned on each other in a public social media spat that quickly became an online spectacle. While the internet grabbed its popcorn to watch the drama/comedy unfold, investors were less amused, driving the stock down and wiping out a record $152 billion in market value. Confident Investing Starts Here: Trump warned he might yank Elon's federal subsidies and contracts, while Musk took jabs at Trump's links to Jeffrey Epstein and called for his impeachment. Now, Trump says he's considering ditching his Tesla. But what does Wall Street have to say about all this madness? Morgan Stanley analyst Adam Jonas, one of the Street's biggest TSLA bulls, shared a 'few 'pith and marrow' thoughts' in the wake of the public spat. According to Trump, the whole thing kicked off because Musk was upset his 'Big Beautiful Bill' was not beneficial to Tesla. However, Jonas makes short shrift of the implications. 'We do not believe the phasing out of EV tax credits from the BBB (Big Beautiful Bill) is material to the long term outlook for TSLA,' the analyst said While Musk's involvement with the Trump administration and his increasingly polarizing politics were the cue from a massive drop in sales for Tesla earlier this year, Jonas does not think the argument will help bring back buyers that once considered buying a Tesla but were turned off by Musk's recent activities. In fact, Jonas thinks the argument could 'potentially (temporarily) alienate multiple sides of the political spectrum.' Yet, zooming out, Jonas thinks it's important to keep an eye on the bigger picture and that offers plenty of promise. 'While emotions are running high, we are not convinced the longer-term vectors that drive the stock's value have changed here,' he said. ' AI leadership, autonomy/robotics, manufacturing, supply chain re-architecture, renewable power, critical infrastructure… Tesla still holds so many valuable cards that are largely apolitical, in our opinion.' Nevertheless, investors should prepare for a rocky ride over the near-term. Donning his 'trading cap,' Jonas feels more confident about short-term volatility than about the stock's immediate direction. The analyst says he's sticking with his $410 price target on Tesla shares, even as he braces for the stock to post further losses. That figure implies a one-year gain of 36%. Meanwhile, Jonas maintains an Overweight rating (i.e., Buy). (To watch Jonas' track record, click here) That view, however, stands in contrast to the broader Street sentiment. Based on a mix of 16 Buys, 10 Holds, and 10 Sells, the analyst consensus rates the stock a Hold (i.e., Neutral). Going by the $285.91 average target, the shares are expected stay range-bound for the foreseeable future. (See TSLA stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Business Insider
an hour ago
- Business Insider
Lululemon Athletica (LULU) Gets a Hold from Barclays
Barclays analyst Adrienne Yih maintained a Hold rating on Lululemon Athletica (LULU – Research Report) on June 6 and set a price target of $270.00. The company's shares closed last Friday at $265.27. Confident Investing Starts Here: Yih covers the Consumer Cyclical sector, focusing on stocks such as American Eagle, Dick's Sporting Goods, and VF. According to TipRanks, Yih has an average return of 6.4% and a 49.70% success rate on recommended stocks. In addition to Barclays, Lululemon Athletica also received a Hold from Morgan Stanley's Alexandra Straton in a report issued yesterday. However, on June 6, KeyBanc reiterated a Buy rating on Lululemon Athletica (NASDAQ: LULU). Based on Lululemon Athletica's latest earnings release for the quarter ending February 2, the company reported a quarterly revenue of $3.61 billion and a net profit of $748.4 million. In comparison, last year the company earned a revenue of $3.21 billion and had a net profit of $669.47 million
Business Upturn
an hour ago
- Business Upturn
Ericsson bags multi-year NOC Managed Services contract with Bharti Airtel
Ericsson (NASDAQ: ERIC) has been awarded a significant multi-year Network Operations Center (NOC) Managed Services contract by Bharti Airtel, reinforcing the strong and enduring partnership between the two telecom giants. This strategic collaboration highlights Ericsson's leadership in managed services and its commitment to delivering superior network performance and value to Airtel's customers. Under this new agreement, Ericsson will deploy its advanced intent-based operations through a centralized NOC to efficiently manage Bharti Airtel's diverse network services. These include 4G, 5G Non-Standalone (NSA), 5G Standalone (SA), Fixed Wireless Access (FWA), Private Networks, and Network Slicing. The move aims to enhance network reliability, scalability, and innovation across Airtel's pan-India footprint. Ericsson's state-of-the-art NOC will play a crucial role in managing and scaling Airtel's expansive network infrastructure, especially focusing on expanding Fixed Wireless Access and Network Slicing capabilities throughout the country. This will empower Airtel to offer improved connectivity solutions and cater to evolving customer demands in the 5G era. Randeep Sekhon, CTO of Bharti Airtel, stated, 'We are excited to enhance our strong collaboration with Ericsson as we pursue our goal of creating a future-ready network that delivers an exceptional experience for our customers. We believe that these innovative technologies will empower us to meet the growing data demands of consumers in a digitally connected India.' With a partnership spanning over 25 years, Ericsson and Bharti Airtel have collaborated across multiple generations of mobile communication technologies. This latest contract follows Airtel's recent collaboration with Ericsson on 5G Core technology, further driving the evolution of India's 5G ecosystem. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
